- 5-Star Big Cap Stocks

- Video: Sell Your Gold?

- Strategists: Embrace The Fear and Buy!

- Be Savvy: Play the Homebuilders

- Why Steel Stocks Will Beat Downturn

- Options Focus on Mines, Nokia and Chips

- Stock Picker: Check Out China

- 4-Star Mid-Cap Stocks

- Video: The Strong-Dollar Commodity Play

- Stock Picks: Jump On The Upturn

- 5-Star Big Cap Stocks
Millennium Pharmaceuticals [MLNM
Loading...
()
] shares soared 70 percent since March -- when Friedman, Billings, Ramsey's David Khani recommended it.
So what does he have his eye on now? One engineering/construction company, one health-care company, and two energy companies, all likely to weather economic slowdowns at home -- and even overseas.
Recommendations:
The engineering/construction company is URS [URS
Loading...
()
].
"[It's] leveraged to the renaissance in nuclear construction," he said. "It trades at a 30 percent discount to its peers, and is positioned to raise guidance in July."
"Cephalon [CEPH
Loading...
()
] is our health-care company," he continued. "That is a specialty pharmaceutical company; it's pulled back nicely on expectations of one of its drugs coming off patent in 2012."
Khani says a new Cephalon drug is expected to help the stock when it comes on line.
His first energy pick is Consol Energy [CNX
Loading...
()
].
"Consol is tied into the coal story," he said. "Today, we've seen countries like Vietnam talk about stopping exports of coal; India's power plants are very short of coal and getting worse; and China, as you know, has inventory problems as well."
He also likes Core Laboratories [CLB
Loading...
()
], a provider of services related to petroleum reservoirs. The company is active in more than 50 countries.
Disclosures:
Khani's firm acts as a market maker for securities of Cephalon and Consol Energy.




